127 related articles for article (PubMed ID: 3862191)
1. [Acute lymphoblastic leukemia L3 in Hodgkin's disease in remission: primary or secondary leukosis?].
Musto P; Lucchi T; Barbieri D; Ferraresi P; Lanza F
Recenti Prog Med; 1985 Apr; 76(4):194-8. PubMed ID: 3862191
[No Abstract] [Full Text] [Related]
2. [Acute lymphoblastic leukemia, Burkitt-cell type, after Hodgkin's disease. Study of 2 cases].
Zandecki M; Dupriez B; Laï JL; Fenaux P; Facon T; Lepelley P; Estienne MH; Huart JJ; Jouet JP
Nouv Rev Fr Hematol (1978); 1987; 29(6):365-9. PubMed ID: 3330607
[TBL] [Abstract][Full Text] [Related]
3. [Second tumors in patients treated for Hodgkin's disease].
España P; Bonilla F; Yebra M; Diego J; Alvarez de Mon M; Marazuela M; Durántez A
Rev Clin Esp; 1988 Apr; 182(6):304-6. PubMed ID: 3406475
[No Abstract] [Full Text] [Related]
4. [Hodgkin's disease. Study of 100 cases].
Sans-Sabrafen J; Pedro Olivé C; Buxó Costa J; Pardo Peret P; Rodríguez Ferrera JC; Woessner S; Galofré M; Rodríguez Méndez F
Med Clin (Barc); 1987 Feb; 88(5):175-8. PubMed ID: 3561046
[No Abstract] [Full Text] [Related]
5. Mopp chemotherapy in the treatment of stage IV Hodgkin's disease.
Fiacchini M; Lauria F; Mazza P; Cantore M; Gherlinzoni F; Tura S
Haematologica; 1985; 70(2):148-54. PubMed ID: 3924778
[No Abstract] [Full Text] [Related]
6. Hodgkin's disease, splenectomy and secondary leukemia.
Centurioni R; Brianzoni F; Leoni P; Danieli G
Haematologica; 1993; 78(4):258-9. PubMed ID: 8294062
[No Abstract] [Full Text] [Related]
7. [CVP or C-MOPP combination chemotherapy in the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma (intermediate grade of working formulation)].
Sampi K; Honda T; Hattori M
Rinsho Ketsueki; 1984 Feb; 25(2):164-8. PubMed ID: 6547984
[No Abstract] [Full Text] [Related]
8. [Hodgkin's disease in children; treatment results with or without radiotherapy].
van Bunningen BN; Dewit L; Bartelink H
Ned Tijdschr Geneeskd; 1986 May; 130(20):928-9. PubMed ID: 3755223
[No Abstract] [Full Text] [Related]
9. Case report: multiagent chemotherapy of Hodgkin's disease associated with red cell aplasia, acquired ichthyosis and anhidrosis.
Homeida M; Mukhtar ED; Daneshmend T; Omer A
East Afr Med J; 1987 May; 64(5):339-41. PubMed ID: 3125033
[No Abstract] [Full Text] [Related]
10. Current status and new vistas in combination chemotherapy.
Frei E
Mt Sinai J Med; 1985 Jun; 52(6):460-4. PubMed ID: 3875026
[No Abstract] [Full Text] [Related]
11. [Treatment of Hodgkin's disease including the staging laparotomy].
Yosida T; Nakanisi J; Kobayasi S; Ohtake S; Ito K; Nakamura S; Hattori K; Saito Y; Tanimoto K
Rinsho Ketsueki; 1984 Jun; 25(6):827-34. PubMed ID: 6548266
[No Abstract] [Full Text] [Related]
12. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M
Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496
[TBL] [Abstract][Full Text] [Related]
13. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
14. Plasma and leukocytic bactericidal activity in the course of chemotherapy of Hodgkin's disease.
Wysocka J; Kemona H; Prokopowicz J; Kiluk S
Acta Med Pol; 1987; 28(1-4):99-107. PubMed ID: 3506375
[No Abstract] [Full Text] [Related]
15. [Primary gastric Hodgkin's disease].
Bo YK
Zhonghua Zhong Liu Za Zhi; 1985 Sep; 7(5):392-3. PubMed ID: 3841508
[TBL] [Abstract][Full Text] [Related]
16. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
Constine LS
J Clin Oncol; 1998 Mar; 16(3):1235. PubMed ID: 9508214
[No Abstract] [Full Text] [Related]
17. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Oliveira JS
Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131
[TBL] [Abstract][Full Text] [Related]
18. [Non-Hodgkin's lymphoma in a patient after many years of remission of Hodgkin's disease].
Kaźmierczak M; Komarnicki M; Kroll R
Acta Haematol Pol; 1995; 26(3):311-3. PubMed ID: 8525778
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
Vassilakopoulos TP; Angelopoulou MK; Siakantaris MP; Kontopidou FN; Dimopoulou MN; Kokoris SI; Kyrtsonis MC; Tsaftaridis P; Karkantaris C; Anargyrou K; Boutsis DE; Variamis E; Michalopoulos T; Boussiotis VA; Panayiotidis P; Papavassiliou C; Pangalis GA
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):765-81. PubMed ID: 15183480
[TBL] [Abstract][Full Text] [Related]
20. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
